Literature DB >> 17088347

Leishmania-derived murine monocyte chemoattractant protein 1 enhances the recruitment of a restrictive population of CC chemokine receptor 2-positive macrophages.

Sean M Conrad1, Dalit Strauss-Ayali, Ann E Field, Matthias Mack, David M Mosser.   

Abstract

Transgenic Leishmania parasites that encode the murine chemokine monocyte chemoattractant protein 1 (MCP-1) were generated. These parasites transcribed MCP-1 mRNA and secreted MCP-1 protein. Infection of BALB/c, C57BL/6, or MCP-1 knockout (KO) mice with these parasites resulted in minimal lesion development with fewer parasites in the infected foot, lymph node, and spleen compared to wild-type-infected mice. In contrast, transgenic parasites caused substantial lesions with relatively high numbers of parasites in CC chemokine receptor 2 (CCR2) KO mice, indicating that the parasites are viable and healthy and that the lack of lesion development is CCR2 dependent. Prior infection of mice with transgenic parasites offered no protection to subsequent wild-type L. major challenge, suggesting that the transgenic parasites are controlled by an early innate immune response. Consistent with innate immunity, flow cytometry of cells from the ears of mice infected with transgenic parasites revealed an increase in the number of CCR2-positive macrophages by day 7 postinfection. The enumeration of transgenic parasites in ear lesions demonstrated a significant reduction in parasite numbers, which coincided with the increased CCR2-positive macrophage migration. CCR2-positive macrophages isolated from ears of mice infected with transgenic parasites contained virtually no parasites. In vitro studies revealed that optimal parasite killing required the recruitment of CCR2-positive macrophages, followed by stimulation with a combination of both MCP-1 and gamma interferon (IFN-gamma). This work suggests that the parasite-derived MCP-1 can recruit a restrictive population of CCR2-positive macrophages into lesions that can be optimally stimulated by MCP-1 and IFN-gamma to efficiently kill Leishmania parasites.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17088347      PMCID: PMC1828528          DOI: 10.1128/IAI.01314-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Monocyte chemotactic protein-1 stimulates the killing of leishmania major by human monocytes, acts synergistically with IFN-gamma and is antagonized by IL-4.

Authors:  U Ritter; H Moll
Journal:  Eur J Immunol       Date:  2000-11       Impact factor: 5.532

Review 2.  Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells.

Authors:  Antal Rot; Ulrich H von Andrian
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

3.  Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis.

Authors:  W Peters; H M Scott; H F Chambers; J L Flynn; I F Charo; J D Ernst
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 4.  Chemokine receptors and their role in inflammation and infectious diseases.

Authors:  C Murdoch; A Finn
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

5.  Regulation of nitric oxide production by murine peritoneal macrophages treated in vitro with chemokine monocyte chemoattractant protein 1.

Authors:  S K Biswas; A Sodhi; S Paul
Journal:  Nitric Oxide       Date:  2001-12       Impact factor: 4.427

6.  Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice.

Authors:  M Mack; J Cihak; C Simonis; B Luckow; A E Proudfoot; J Plachý ; H Brühl; M Frink; H J Anders; V Vielhauer; J Pfirstinger; M Stangassinger; D Schlöndorff
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

7.  Leishmania-induced cellular recruitment during the early inflammatory response: modulation of proinflammatory mediators.

Authors:  Claudine Matte; Martin Olivier
Journal:  J Infect Dis       Date:  2002-02-06       Impact factor: 5.226

Review 8.  Divergent expression of inflammatory dermal chemokines in cutaneous leishmaniasis.

Authors:  Uwe Ritter; Heinrich Körner
Journal:  Parasite Immunol       Date:  2002-06       Impact factor: 2.280

9.  Chemokine-induced leishmanicidal activity in murine macrophages via the generation of nitric oxide.

Authors:  Sandip Bhattacharyya; Sanjukta Ghosh; Biplab Dasgupta; Debashis Mazumder; Syamal Roy; Subrata Majumdar
Journal:  J Infect Dis       Date:  2002-05-31       Impact factor: 5.226

10.  The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure.

Authors:  Y Belkaid; K F Hoffmann; S Mendez; S Kamhawi; M C Udey; T A Wynn; D L Sacks
Journal:  J Exp Med       Date:  2001-11-19       Impact factor: 14.307

View more
  20 in total

Review 1.  Therapeutic antibodies directed at G protein-coupled receptors.

Authors:  Catherine J Hutchings; Markus Koglin; Fiona H Marshall
Journal:  MAbs       Date:  2010-11-01       Impact factor: 5.857

Review 2.  Invasion and intracellular survival by protozoan parasites.

Authors:  L David Sibley
Journal:  Immunol Rev       Date:  2011-03       Impact factor: 12.988

3.  Reduced pathology following infection with transgenic Leishmania major expressing murine CD40 ligand.

Authors:  Ann E Field; Sagie Wagage; Sean M Conrad; David M Mosser
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

4.  Intermediate monocytes contribute to pathologic immune response in Leishmania braziliensis infections.

Authors:  Sara Passos; Lucas P Carvalho; Rúbia S Costa; Taís M Campos; Fernanda O Novais; Andréa Magalhães; Paulo R L Machado; Daniel Beiting; David Mosser; Edgar M Carvalho; Phillip Scott
Journal:  J Infect Dis       Date:  2014-08-19       Impact factor: 5.226

5.  Murine immune response induced by Leishmania major during the implantation of paraffin tablets.

Authors:  Maria Letícia Costa Reis; Vanessa Martins Ferreira; Xia Zhang; Ricardo Gonçalves; Leda Quércia Vieira; Washington Luiz Tafuri; David M Mosser; Wagner Luiz Tafuri
Journal:  Virchows Arch       Date:  2010-09-21       Impact factor: 4.064

6.  CCR2 receptor is essential to activate microbicidal mechanisms to control Toxoplasma gondii infection in the central nervous system.

Authors:  Luciana Benevides; Cristiane Maria Milanezi; Lucy Megumi Yamauchi; Cláudia Farias Benjamim; João Santana Silva; Neide Maria Silva
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

7.  Monocyte subpopulations as important biomarkers of resistence and susceptibility during experimental infection with Leishmania (Leishmania) major.

Authors:  Tassiane Assiria Fontes Martins; Vitor Silva Barbosa; Gregório Guilherme Almeida; Lis Ribeiro Do Valle Antonelli; Wagner Luiz Tafuri; David M Mosser; Ricardo Gonçalves
Journal:  Biomed Pharmacother       Date:  2018-09-05       Impact factor: 6.529

Review 8.  Monocyte-mediated defense against microbial pathogens.

Authors:  Natalya V Serbina; Ting Jia; Tobias M Hohl; Eric G Pamer
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

9.  Caffeic acid combined with autoclaved Leishmania major boosted the protection of infected BALB/c mice by enhancing IgG2 production, IFN-γ/TGF-β and iNO synthase/arginase1 ratios, and the death of infected phagocytes.

Authors:  Radia Belkhelfa-Slimani; Bahia Djerdjouri
Journal:  Inflammopharmacology       Date:  2017-10-07       Impact factor: 4.473

Review 10.  Transgenic Leishmania and the immune response to infection.

Authors:  L Beattie; K J Evans; P M Kaye; D F Smith
Journal:  Parasite Immunol       Date:  2008-02-04       Impact factor: 2.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.